PMGC Holdings Closes Second Secured Pre-Paid Equity Deal
TipRanks (Mon, 12-Jan 5:18 PM ET)
Globe Newswire (Tue, 6-Jan 7:30 AM ET)
PMGC Holdings Inc. Announces Reverse Stock Split Effective January 6, 2026
Globe Newswire (Mon, 5-Jan 11:00 PM ET)
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split
Globe Newswire (Fri, 2-Jan 11:30 AM ET)
Globe Newswire (Mon, 22-Dec 7:30 AM ET)
Globe Newswire (Wed, 17-Dec 7:30 AM ET)
Globe Newswire (Thu, 4-Dec 10:58 AM ET)
Globe Newswire (Thu, 30-Oct 8:00 AM ET)
Globe Newswire (Tue, 28-Oct 8:00 AM ET)
Market Chameleon (Mon, 20-Oct 4:19 AM ET)
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
PMGC Holdings trades on the NASDAQ stock market under the symbol ELAB.
As of January 12, 2026, ELAB stock price climbed to $5.27 with 239,378 million shares trading.
ELAB has a beta of 1.95, meaning it tends to be more sensitive to market movements. ELAB has a correlation of 0.06 to the broad based SPY ETF.
ELAB has a market cap of $2.65 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that ELAB belongs to (by Net Assets): VXF.
ELAB has underperformed the market in the last year with a price return of -97.4% while the SPY ETF gained +21.0%. ELAB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -75.9% and -5.9%, respectively, while the SPY returned +6.8% and +1.1%, respectively.
ELAB support price is $4.52 and resistance is $5.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ELAB shares will trade within this expected range on the day.
